These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 25531328

  • 1. Loss of ATF3 promotes Akt activation and prostate cancer development in a Pten knockout mouse model.
    Wang Z, Xu D, Ding HF, Kim J, Zhang J, Hai T, Yan C.
    Oncogene; 2015 Sep 17; 34(38):4975-84. PubMed ID: 25531328
    [Abstract] [Full Text] [Related]

  • 2. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
    Tan M, Xu J, Siddiqui J, Feng F, Sun Y.
    Mol Cancer; 2016 Dec 12; 15(1):81. PubMed ID: 27955654
    [Abstract] [Full Text] [Related]

  • 3. Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis.
    Zhong C, Saribekyan G, Liao CP, Cohen MB, Roy-Burman P.
    Cancer Res; 2006 Feb 15; 66(4):2188-94. PubMed ID: 16489020
    [Abstract] [Full Text] [Related]

  • 4. Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium.
    Fu Y, Wey S, Wang M, Ye R, Liao CP, Roy-Burman P, Lee AS.
    Proc Natl Acad Sci U S A; 2008 Dec 09; 105(49):19444-9. PubMed ID: 19033462
    [Abstract] [Full Text] [Related]

  • 5. PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL/6 mice via mTOR-dependent growth.
    Blando J, Portis M, Benavides F, Alexander A, Mills G, Dave B, Conti CJ, Kim J, Walker CL.
    Am J Pathol; 2009 May 09; 174(5):1869-79. PubMed ID: 19395652
    [Abstract] [Full Text] [Related]

  • 6. PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling.
    Conley-LaComb MK, Saliganan A, Kandagatla P, Chen YQ, Cher ML, Chinni SR.
    Mol Cancer; 2013 Jul 31; 12(1):85. PubMed ID: 23902739
    [Abstract] [Full Text] [Related]

  • 7. Gata3 antagonizes cancer progression in Pten-deficient prostates.
    Nguyen AH, Tremblay M, Haigh K, Koumakpayi IH, Paquet M, Pandolfi PP, Mes-Masson AM, Saad F, Haigh JJ, Bouchard M.
    Hum Mol Genet; 2013 Jun 15; 22(12):2400-10. PubMed ID: 23428429
    [Abstract] [Full Text] [Related]

  • 8. PTEN loss-mediated Akt activation increases the properties of cancer stem-like cell populations in prostate cancer.
    Kim RJ, Bae E, Hong YK, Hong JY, Kim NK, Ahn HJ, Oh JJ, Park DS.
    Oncology; 2014 Jun 15; 87(5):270-9. PubMed ID: 25139413
    [Abstract] [Full Text] [Related]

  • 9. KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis.
    Li G, Kanagasabai T, Lu W, Zou MR, Zhang SM, Celada SI, Izban MG, Liu Q, Lu T, Ballard BR, Zhou X, Adunyah SE, Matusik RJ, Yan Q, Chen Z.
    Cancer Res; 2020 Nov 01; 80(21):4633-4643. PubMed ID: 32868382
    [Abstract] [Full Text] [Related]

  • 10. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways.
    Xing C, Ci X, Sun X, Fu X, Zhang Z, Dong EN, Hao ZZ, Dong JT.
    Neoplasia; 2014 Nov 01; 16(11):883-99. PubMed ID: 25425963
    [Abstract] [Full Text] [Related]

  • 11. KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation.
    Ci X, Xing C, Zhang B, Zhang Z, Ni JJ, Zhou W, Dong JT.
    Mol Cancer; 2015 Apr 21; 14():91. PubMed ID: 25896712
    [Abstract] [Full Text] [Related]

  • 12. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
    Wu Z, He B, He J, Mao X.
    Prostate; 2013 May 21; 73(6):596-604. PubMed ID: 23060044
    [Abstract] [Full Text] [Related]

  • 13. Posttranslational regulation of membrane type 1-matrix metalloproteinase (MT1-MMP) in mouse PTEN null prostate cancer cells: Enhanced surface expression and differential O-glycosylation of MT1-MMP.
    Kim S, Huang W, Mottillo EP, Sohail A, Ham YA, Conley-Lacomb MK, Kim CJ, Tzivion G, Kim HR, Wang S, Chen YQ, Fridman R.
    Biochim Biophys Acta; 2010 Nov 21; 1803(11):1287-97. PubMed ID: 20620173
    [Abstract] [Full Text] [Related]

  • 14. Timp3 loss accelerates tumour invasion and increases prostate inflammation in a mouse model of prostate cancer.
    Adissu HA, McKerlie C, Di Grappa M, Waterhouse P, Xu Q, Fang H, Khokha R, Wood GA.
    Prostate; 2015 Dec 21; 75(16):1831-43. PubMed ID: 26332574
    [Abstract] [Full Text] [Related]

  • 15. Methylseleninic Acid Superactivates p53-Senescence Cancer Progression Barrier in Prostate Lesions of Pten-Knockout Mouse.
    Wang L, Guo X, Wang J, Jiang C, Bosland MC, Lü J, Deng Y.
    Cancer Prev Res (Phila); 2016 Jan 21; 9(1):35-42. PubMed ID: 26511486
    [Abstract] [Full Text] [Related]

  • 16. CXCR4 and PTEN are involved in the anti-metastatic regulation of anethole in DU145 prostate cancer cells.
    Rhee YH, Chung PS, Kim SH, Ahn JC.
    Biochem Biophys Res Commun; 2014 May 16; 447(4):557-62. PubMed ID: 24525130
    [Abstract] [Full Text] [Related]

  • 17. Constitutive activation of P I3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model.
    Shukla S, Maclennan GT, Marengo SR, Resnick MI, Gupta S.
    Prostate; 2005 Aug 01; 64(3):224-39. PubMed ID: 15712212
    [Abstract] [Full Text] [Related]

  • 18. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis.
    Song H, Zhang B, Watson MA, Humphrey PA, Lim H, Milbrandt J.
    Oncogene; 2009 Sep 17; 28(37):3307-19. PubMed ID: 19597465
    [Abstract] [Full Text] [Related]

  • 19. NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence.
    Manda KR, Tripathi P, Hsi AC, Ning J, Ruzinova MB, Liapis H, Bailey M, Zhang H, Maher CA, Humphrey PA, Andriole GL, Ding L, You Z, Chen F.
    Oncogene; 2016 Jun 23; 35(25):3282-92. PubMed ID: 26477312
    [Abstract] [Full Text] [Related]

  • 20. NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss.
    Lei Q, Jiao J, Xin L, Chang CJ, Wang S, Gao J, Gleave ME, Witte ON, Liu X, Wu H.
    Cancer Cell; 2006 May 23; 9(5):367-78. PubMed ID: 16697957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.